Literature DB >> 24535828

Considering specific clinical features as evidence of pathogenic copy number variants.

Egle Preiksaitiene1, Alma Molytė, Jurate Kasnauskiene, Zivile Ciuladaite, Algirdas Utkus, Philippos C Patsalis, Vaidutis Kučinskas.   

Abstract

Since the introduction of high-resolution microarray technologies, it has become apparent that structural chromosomal rearrangements can lead to a wide variety of clinical manifestations, including developmental delay/intellectual disability (DD/ID). It has been shown previously that the diagnostic yield of genome-wide array-based identification of submicroscopic alterations in patients with ID varies widely and depends on the patient selection criteria. More attempts have recently been made to define the phenotypic clues of pathogenic copy number variants (CNVs). The aim of this study was to investigate a well-phenotyped cohort of patients with DD/ID and determine whether certain clinical features may serve as indicators for pathogenic CNVs. A retrospective analysis was conducted for patients with DD/ID (n = 211) who were tested using genome-wide chromosomal microarray technologies and a review of the clinical data was performed. Pathogenic CNVs were detected in 29 patients. In comparison with individuals who had normal molecular karyotyping results (n = 182), malformations of the musculoskeletal system; congenital malformations of the CNS (particularly hydrocephalus and congenital malformations of the corpus callosum); minor anomalies of the eye, face, and neck subgroup (particularly downward-slanting palpebral fissures, minor anomalies of the ear, and micrognathia); brachydactyly; and umbilical hernia were more common in patients with chromosomal alterations. A multivariate logistic regression analysis allowed the identification of three independent pathogenic CNV predictors: congenital malformations of the corpus callosum, minor anomalies of the ear, and brachydactyly. Insights into the chromosomal phenotype may help to increase the diagnostic yield of microarray technologies and sharpen the distinction between chromosomal alterations and other conditions.

Entities:  

Mesh:

Year:  2014        PMID: 24535828     DOI: 10.1007/s13353-014-0197-x

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  28 in total

1.  Array CGH in patients with developmental delay or intellectual disability: are there phenotypic clues to pathogenic copy number variants?

Authors:  M Shoukier; N Klein; B Auber; J Wickert; J Schröder; B Zoll; P Burfeind; I Bartels; E A Alsat; M Lingen; P Grzmil; S Schulze; J Keyser; D Weise; M Borchers; E Hobbiebrunken; M Röbl; J Gärtner; K Brockmann; B Zirn
Journal:  Clin Genet       Date:  2012-02-21       Impact factor: 4.438

2.  Two distinct regions in 2q24.2-q24.3 associated with idiopathic epilepsy.

Authors:  Ana Cristina Victorino Krepischi; Jeroen Knijnenburg; Debora Romeo Bertola; Chong Ae Kim; Peter Lees Pearson; Emilia Bijlsma; Karoly Szuhai; Fernando Kok; Angela Maria Vianna-Morgante; Carla Rosenberg
Journal:  Epilepsia       Date:  2010-09-30       Impact factor: 5.864

Review 3.  Genome arrays for the detection of copy number variations in idiopathic mental retardation, idiopathic generalized epilepsy and neuropsychiatric disorders: lessons for diagnostic workflow and research.

Authors:  R Hochstenbach; J E Buizer-Voskamp; J A S Vorstman; R A Ophoff
Journal:  Cytogenet Genome Res       Date:  2011-11-02       Impact factor: 1.636

Review 4.  Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.

Authors:  David T Miller; Margaret P Adam; Swaroop Aradhya; Leslie G Biesecker; Arthur R Brothman; Nigel P Carter; Deanna M Church; John A Crolla; Evan E Eichler; Charles J Epstein; W Andrew Faucett; Lars Feuk; Jan M Friedman; Ada Hamosh; Laird Jackson; Erin B Kaminsky; Klaas Kok; Ian D Krantz; Robert M Kuhn; Charles Lee; James M Ostell; Carla Rosenberg; Stephen W Scherer; Nancy B Spinner; Dimitri J Stavropoulos; James H Tepperberg; Erik C Thorland; Joris R Vermeesch; Darrel J Waggoner; Michael S Watson; Christa Lese Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2010-05-14       Impact factor: 11.025

5.  Clinical and molecular characterization of chromosome 7p22.1 microduplication detected by array CGH.

Authors:  Jacqueline V Chui; James D Weisfeld-Adams; James Tepperberg; Lakshmi Mehta
Journal:  Am J Med Genet A       Date:  2011-10       Impact factor: 2.802

6.  Two new de novo interstitial duplications covering 2p14-p22.1: clinical and molecular analysis.

Authors:  J Kasnauskiene; L Cimbalistiene; A Utkus; Z Ciuladaite; E Preiksaitiene; A Pečiulytė; V Kučinskas
Journal:  Cytogenet Genome Res       Date:  2012-10-02       Impact factor: 1.636

7.  Disruption of CNTNAP2 and additional structural genome changes in a boy with speech delay and autism spectrum disorder.

Authors:  Martin Poot; Vera Beyer; Ira Schwaab; Natalja Damatova; Ruben Van't Slot; Jo Prothero; Sue E Holder; Thomas Haaf
Journal:  Neurogenetics       Date:  2009-07-07       Impact factor: 2.660

Review 8.  Karyotype-phenotype correlations in autosomal chromosomal aberrations.

Authors:  A Schinzel
Journal:  Prog Clin Biol Res       Date:  1993

9.  Clinical significance of de novo and inherited copy-number variation.

Authors:  Anneke T Vulto-van Silfhout; Jayne Y Hehir-Kwa; Bregje W M van Bon; Janneke H M Schuurs-Hoeijmakers; Stephen Meader; Claudia J M Hellebrekers; Ilse J M Thoonen; Arjan P M de Brouwer; Han G Brunner; Caleb Webber; Rolph Pfundt; Nicole de Leeuw; Bert B A de Vries
Journal:  Hum Mutat       Date:  2013-10-10       Impact factor: 4.878

10.  Both rare and de novo copy number variants are prevalent in agenesis of the corpus callosum but not in cerebellar hypoplasia or polymicrogyria.

Authors:  Samin A Sajan; Liliana Fernandez; Sahar Esmaeeli Nieh; Eric Rider; Polina Bukshpun; Mari Wakahiro; Susan L Christian; Jean-Baptiste Rivière; Christopher T Sullivan; Jyotsna Sudi; Michael J Herriges; Alexander R Paciorkowski; A James Barkovich; Joseph T Glessner; Kathleen J Millen; Hakon Hakonarson; William B Dobyns; Elliott H Sherr
Journal:  PLoS Genet       Date:  2013-10-03       Impact factor: 5.917

View more
  5 in total

1.  Single gene microdeletions and microduplication of 3p26.3 in three unrelated families: CNTN6 as a new candidate gene for intellectual disability.

Authors:  Anna A Kashevarova; Lyudmila P Nazarenko; Soren Schultz-Pedersen; Nikolay A Skryabin; Olga A Salyukova; Nataliya N Chechetkina; Ekaterina N Tolmacheva; Aleksey A Rudko; Pamela Magini; Claudio Graziano; Giovanni Romeo; Shelagh Joss; Zeynep Tümer; Igor N Lebedev
Journal:  Mol Cytogenet       Date:  2014-12-31       Impact factor: 2.009

2.  Prematurity, ventricular septal defect and dysmorphisms are independent predictors of pathogenic copy number variants: a retrospective study on array-CGH results and phenotypical features of 293 children with neurodevelopmental disorders and/or multiple congenital anomalies.

Authors:  I Maini; I Ivanovski; O Djuric; S G Caraffi; E Errichiello; M Marinelli; F Franchi; V Bizzarri; S Rosato; M Pollazzon; C Gelmini; M Malacarne; C Fusco; G Gargano; S Bernasconi; O Zuffardi; L Garavelli
Journal:  Ital J Pediatr       Date:  2018-03-09       Impact factor: 2.638

3.  Rare Copy Number Variations and Predictors in Children With Intellectual Disability and Epilepsy.

Authors:  Miriam Kessi; Juan Xiong; Liwen Wu; Lifen Yang; Fang He; Chen Chen; Nan Pang; Haolin Duan; Wen Zhang; Ahmed Arafat; Fei Yin; Jing Peng
Journal:  Front Neurol       Date:  2018-11-19       Impact factor: 4.003

4.  CNV analysis in the Lithuanian population.

Authors:  A Urnikyte; I Domarkiene; S Stoma; L Ambrozaityte; I Uktveryte; R Meskiene; V Kasiulevičius; N Burokiene; V Kučinskas
Journal:  BMC Genet       Date:  2016-05-04       Impact factor: 2.797

5.  A case report of familial 4q13.3 microdeletion in three individuals with syndromic intellectual disability.

Authors:  Živilė Maldžienė; Evelina M Vaitėnienė; Beata Aleksiūnienė; Algirdas Utkus; Eglė Preikšaitienė
Journal:  BMC Med Genomics       Date:  2020-04-16       Impact factor: 3.063

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.